Tuberculosis is a fairly frequent complication of leprosy, par ticularly in lepromin-negative lepromatous cases, and is often a direct cause of death in this disease. For instance Gray and Ban croft (1952) attribute to it 21.7% of deaths at Carville Hospital in the pre-sulphone era. Similar figures have been reported by other workers .
The following observations have been made on treatment of tuberculosis in leprous patients in Ossiomo Settlement in. Nigeria. In 19 4 5 this settlement became the centre of leprosy control of the Benin and Delta provinces in Western Nigeria. Segregation villages were established in these two provinces, and, as more and more patients came under the medical supervision of the staff of Ossiomo Settlement, more and more cases of tuberculosis were dia; gnosed. Naturally with two medical officers in charge of a fluctuating popu lation of about 5000 patients, and with no X-ray facilities, it has been impossible to diagnose early cases. Only when a patient had been noticed to be losing weight at an abnormal rate or to have a constant rise in temperature or persistent cough , he was examined by the touring Medical Officer and his sputum tested for acid fast' bacilli. If tuberculosis had been diagnosed, the patient was trans ferred to the settlement and segregated there in an isolation ward. He continued receiving the anti-leprosy treatment, and, in addition, a diet ri.h in proteins and vitamin preparations. The mortality rate was very high, and few of these patients survived . In the five years between 19 4 7 and 1951, tuberculosis of lungs was diagnosed in 50 patients out of whom 45 have died. Sulphone treatment was introduced in this area gradually in 1950 and early in 195I. Unlike Carville Hospital. there has been no appreciable improvement, here, as far as tuberculosis is concerned. There might have been a de crease in morbidity difficult at present to assess because of the in crease of the number of patients owing to the simultaneous increase in the number of segregation villages. There has been no change whatever in case mortality. The present trial was undertaken chiefly from the point of view of treatment of tuberculosis. Very few of the patients would have been selected if the main purpose were evaluation of the action of drugs on leprosy. Nevertheless it was thought that some useful results might be gained also in this direction.
The treatment was started in September 1953 . In that month , 13 patients who had been treated with thiosemicarbazone for 9-20 months were put on streptomycin and isoniazid. All these patients had symptoms of active open tuberculosis of lungs. Five more patients were added to the trial later. In three of them, tuberculosis of lungs had been diagnosed, in one tuberculosis lymphadenitis, and one was suspected of having tuberculosis laryngitis. They have been all receiving intramuscular injections of I gram of streptomycin on alternate days, and IOomg of isoniazid twice daily . Both drugs were given continuously. Two patients in whom acid-fast bacilli did not disappear from the sputum in four to five months were changed from streptomycin to para-aminosalicylic acid 20 grams daily, while isoniazid was continued in the same dosage. It was thought that their tubercle bacilli might have become resistant to streptomycin. The patients were weighed every month and their sputum tested for acid-fast bacilli. They were examined in three monthly intervals from the point of view of leprosy (bacteriological smears and clinical examination) . Unfortunately it has not been possible to have X-ray examinations and to culture their bacilli and test them from the point of view of acquired resistance to the drugs . Physical signs of tuberculosis of lungs and scanty acid-fast bacilli in sputum found in Novem ber 1 953. Transferred to the settlement and put on the present trial in February 1954 . Acid-fast bacilli did not reappear in sputum, and physical signs subsided . In the beginning of the trial she had large well defined erythematous macules all over her body. There was no improvement after four months of treatment with streptomycin and isoniazid.
Case 17. Female, aged 25. Admitted to a �egregation village in October 1952 with lepromatous leprosy and put on DDS. In February 1954 she was transferred to the settlement because of tuberculous lymphadenitis of cervical glands with sinuses discharging pus. She was put on the present trial. Inflammation of glands subsided and sinuses healed promptly. There was no clinical or bacteriological improvement in her leprosy during the four months of treatment.
Case 18. Male, aged 30. Adm itted in April 1953 with tuberculoid leprosy. He had a persistent hoarseness which was suspected to be possibly due to tuberculous laryngitis. Therefore he was put on thiosemicarbazone. In January 1954, transferred to the present trial. However, his hoarseness continued, and after five months of treatment without effect it was assumed that his condition was not due to tuberculosis. His case is interesting from the point of view of leprosy. At the beginning of the trial he had scattered vividly erythematous macules with marginal elevation almost resembling a reactional stage of tuberculoid leprosy . There was no improvement what ever following five months of treatment with streptomycin and isoniazid.
CONCLUSIONS .
These have to be considered separately from the point of view of action of the drugs on tuberculosis and on leprosy.
As described before, until the introduction of lreatment with thiosemicarbazone the outlook for our patients who had developed severe tuberculosis of lungs was very bleak . The diagnosis of open tuberculosis of lungs was for them almost tantamount to the verdict of death. The situation had improved with the introduction of treatment with thiosemicarbazone. The death rate had fallen to a great extent but only one patient had been cured of the tuberculous infection. Some of the remaining ones improved but all continued to discharge bacilli in their sputum and one (case 12) was actually on the point of death when put on the streptomycin and isoniazid treatment. With the introduction of this treatment, the situation has changed radically. After few weeks, a great subjective im provement was noticed in all patients. They were almost in a state of euphoria, extremely grateful for the " new treatment " . In two to four months, in all except one (case 12) acid-fast bacilli have disappeared from the sputum, although in one of them it did not happen until he has been changed from streptomycin to para aminosalicylic acid. One patient (case 3) , who arrived with acute tuberculous pneumonia at the beginning of the trial, has shown just as good results as the others. The same can be said about one patient (case 17) who was suffering from tuberculous lymphadenitis.
None of the patients has had any side effects from the treatment, and in none of them has there been any need to stop treatment even temporarily. Only one patient (case 12) has shown disappointing results although there is little doubt that the treatment has at least for the time being saved her life.
The situation is different where the action on leprosy is con cerned. All these patients have been already receiving treatment before the beginning of the present trial, either with DDS or thio semicarbazone . Only in ten of them leprosy has been still active. Two were tuberculoid and ten lepromatous. No improvement has been observed in the two tuberculoid cases after four and five months of treatment respectively. Among lepromatous cases no bacterio logical improvement has been seen in cases 3 , 12 and 17. There was slight bacteriological improvement in cases 3, 10 and 1 4 . Cases 5 and 9 had no clinical signs of leprosy left at the beginning of the trial but skin lesions were bacteriologically positive. They became bacteriologically negative during the trial. However, one has to bear in mind that these patients have had a long period of treatment with DDS or thiosemicarbazone, and the reduction in number and disappearance of bacilli might have been the delayed result of previous treatment. No obvious clinical improvement has been observed in any of the patients.
Conclusions are that the treatment with streptomycin and isoniazid can be highly recommended in tuberculosis complicating leprosy, particularly in leprosaria situated in tropical countries with limited medical staff and no facilities for individualised treatment by specialists in tuberculosis. On the other hand. these experiments seem to show that treatment with isoniazid and streptomycin and also conceivably isoniazid and para-aminosalicylic acid cannot be recommended as treatment for leprosy. They seem to be definitely inferior to sulphones and thiosemicarbazone. apart from being much more expensive. It appears that even in the treatment of tubercu losis in leprous patients. it would be advantagous to combine them with either sulphones or thiosemicarbazone in order to deal effec tively with patient's leprotic condition.
SUMMARY.
1. Until the introduction of thiosemicarbazone there has been in the Benin-Delta Leprosy Control Area in Nigeria a very high mortality rate among leprosy patients with tuberculosis even after the introduction of sulphone drugs .
2. Thiosemicarbazone had diminished appreciably the mort ality rate but only one patient had been cured of tuberculosis with that drug during 18 months of treatment.
3.
In September 1953 all patients with tuberculosis of lungs and lymphatic glands were put on a treatment with I gram of streptomycin on alternate days and 100 mg. of isoniazid twice daily .
4.
In two to three months the sputum of 14 out of 16 has been rendered free of acid-fast bacilli. and the tuberculosis of cervical glands of the only patient on trial with tuberculosis of lymphatic glands has completely regressed. Two patients whose sputum has not been cleared of the bacilli in 4 to 5 months have been changed from streptomycin to PAS, and the sputum of one of them became free of bacilli in a month . Only one patient went on discharging bacil1i after nine months of treatment, but there is no doubt that the treatment has saved her life . The weight of all patients in creased considerably, there has been noticeable subjective improve ment. There have been no side effects and no need to discontinue treatment.
5.
No appreciable improvement in the leprotic condition of the patients has been observed .
6. Treatment with isoniazid and streptomycin or para-amino salicylic acid is highly recommended for leprosy patients with tuber-culosis. In view, however, of the doubtful action of these drugs on leprotic condition, it is recommended to combine this treatment with sulphones or thiosemicarbazone .
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